CVS expands drug delivery across nation

CVS Pharmacy is expanding its delivery service, CarePass, nationwide at participating pharmacy locations, the company announced.

The program, which offers prescription drug delivery for free on select drugs and other benefits for a monthly membership fee, was originally a pilot project in select markets, where CVS found broad appeal from customers. Of its CarePass audience, 20% are millennials, CVS stated.

"Initial customer response has exceeded our expectations with members utilizing the program's full benefits and becoming more engaged across all of our digital offerings,” Kevin Hourican, executive vice president, CVS Health and President, CVS Pharmacy, said in a statement.

Members of CarePass pay $5 per month, or $48 for an annual membership to receive delivery of prescription medications, access to a pharmacist helpline anytime, other special discounts on CVS Health brand items, and a monthly $10 promotional reward for in-store and online items. CarePass members also receive a free sports physical as part of their membership at their local MinuteClinic.

CVS also said it’s seeing a boost in customer purchases of about 15% to 20% from members who join the CarePass program.

The expansion of the program comes at a time when competitors from outside the industry are trying to stake a claim in the space. Amazon purchased online pharmacy PillPack last year as part of its venture into healthcare.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup